Compositions and methods for treating bladder cancer

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9321820
APP PUB NO 20120232010A1
SERIAL NO

13502132

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides methods and compositions for treating bladder cancer. In particular, the present invention provides a fusion protein comprising a toxin moiety that is linked to an epithelial growth factor (EGF) moiety. The toxin moiety and the EGF moiety can be linked optionally via a linker. Typically, the fusion protein is administered intravesically into the cancerous bladder.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
THE REGENTS OF THE UNIVERSITY OF COLORADO A BODY CORPORATE201 REGENT ADMINISTRATIVE CENTER BOULDER CO 80309

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Flaig, Thomas Englewood, US 3 3
Frankel, Arthur E Temple, US 23 645
Glode, Michael L Golden, US 1 0
Thorburn, Andrew Denver, US 2 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Oct 26, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00